Riggs Asset Managment Co. Inc. - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 238 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
Riggs Asset Managment Co. Inc. ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$13,546
-13.0%
6500.0%0.01%0.0%
Q2 2023$15,568
+27.3%
6500.0%0.01%0.0%
Q1 2023$12,233
+18.2%
6500.0%0.01%
+25.0%
Q4 2022$10,348
-5.9%
6500.0%0.00%0.0%
Q3 2022$11,000
+22.2%
6500.0%0.00%0.0%
Q2 2022$9,000
-43.8%
6500.0%0.00%
-20.0%
Q1 2022$16,000
+6.7%
6500.0%0.01%
+25.0%
Q4 2021$15,000
+36.4%
6500.0%0.00%
+33.3%
Q3 2021$11,000
-31.2%
6500.0%0.00%
-25.0%
Q2 2021$16,000
-5.9%
6500.0%0.00%
-20.0%
Q1 2021$17,000
-51.4%
6500.0%0.01%
-54.5%
Q4 2020$35,000
-98.3%
650
-96.3%
0.01%
-98.7%
Q3 2020$2,025,000
+6432.3%
17,470
+2587.7%
0.85%
+6461.5%
Q2 2020$31,000
+14.8%
6500.0%0.01%
-23.5%
Q1 2020$27,000
-3.6%
6500.0%0.02%
+54.5%
Q4 2019$28,000
+21.7%
6500.0%0.01%
-8.3%
Q3 2019$23,000
+35.3%
6500.0%0.01%
+20.0%
Q2 2019$17,0000.0%6500.0%0.01%
-16.7%
Q1 2019$17,000
+54.5%
6500.0%0.01%
+50.0%
Q4 2018$11,000
-15.4%
6500.0%0.01%
+33.3%
Q3 2018$13,000
+30.0%
6500.0%0.01%
+50.0%
Q2 2018$10,000
-33.3%
6500.0%0.00%
-33.3%
Q1 2018$15,000
-25.0%
6500.0%0.01%
-25.0%
Q4 2017$20,000
-16.7%
6500.0%0.01%
-27.3%
Q3 2017$24,000
+33.3%
6500.0%0.01%
+37.5%
Q2 2017$18,000
-18.2%
6500.0%0.01%
-27.3%
Q1 2017$22,000
+15.8%
6500.0%0.01%
+22.2%
Q4 2016$19,000
-55.8%
650
-50.0%
0.01%
-66.7%
Q3 2015$43,000
+4.9%
1,3000.0%0.03%
+35.0%
Q4 2014$41,0001,3000.02%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Baker Brothers Advisors 27,228,338$611,821,0005.19%
First Washington CORP 176,950$3,976,0002.06%
SECTORAL ASSET MANAGEMENT INC 783,424$17,604,0001.93%
HARVEY CAPITAL MANAGEMENT INC 219,042$4,921,0001.84%
Ghost Tree Capital, LLC 400,000$8,988,0001.82%
Opus Point Partners Management, LLC 36,733$825,0001.62%
Palo Alto Investors LP 1,650,780$37,093,0001.59%
EMORY UNIVERSITY 84,714$1,904,0001.36%
GARRISON BRADFORD & ASSOCIATES INC 69,000$1,550,0001.32%
HealthCor Management, L.P. 1,378,000$30,964,0001.05%
View complete list of ACADIA PHARMACEUTICALS INC shareholders